Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study.
BACKGROUND: Physicians need to inform asymptomatic individuals about personalized outcomes of statin therapy for primary prevention of cardiovascular disease (CVD). However, current prediction models focus on short-term outcomes and ignore the competing risk of death due to other causes. We aimed to...
Main Authors: | Bart S Ferket, Bob J H van Kempen, Jan Heeringa, Sandra Spronk, Kirsten E Fleischmann, Rogier L G Nijhuis, Albert Hofman, Ewout W Steyerberg, M G Myriam Hunink |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3531501?pdf=render |
Similar Items
-
Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.
by: Bart S Ferket, et al.
Published: (2014-01-01) -
Validation of a model to investigate the effects of modifying cardiovascular disease (CVD) risk factors on the burden of CVD: the rotterdam ischemic heart disease and stroke computer simulation (RISC) model
by: van Kempen Bob JH, et al.
Published: (2012-12-01) -
Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
by: Hassan Saadati, et al.
Published: (2020-11-01) -
Statins: Not all are benefits
by: Isabel García Cuerda, et al.
Published: (2018-10-01) -
Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals
by: Dong-Hyeon Lee, et al.
Published: (2017-09-01)